Luca Leonardi

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial

Silvia Romano, Giulia Coarelli, Christian Marcotulli et al. · The Lancet Neurology · 2015 · 201 citations

Hereditary Cerebellar Ataxia, Placebo-controlled Trial, Rehabilitation +3

ATTRv amyloidosis Italian Registry: clinical and epidemiological data

Massimo Russo, Laura Obici, Ilaria Bartolomei et al. · Amyloid · 2020 · 84 citations

Gait Patterns in Patients with Hereditary Spastic Paraparesis

Mariano Serrao, Martina Rinaldi, Alberto Ranavolo et al. · PLoS ONE · 2016 · 59 citations · Full text

Local Stability of the Trunk in Patients with Degenerative Cerebellar Ataxia During Walking

Giorgia Chini, Alberto Ranavolo, Francesco Draicchio et al. · The Cerebellum · 2016 · 55 citations

Degenerative Cerebellar Ataxia, Kinesiology, Neurological Disorder +8